Homodimerized cytoplasmic domain of PD-L1 regulates its complex glycosylation in living cells
出版年份 2022 全文链接
标题
Homodimerized cytoplasmic domain of PD-L1 regulates its complex glycosylation in living cells
作者
关键词
-
出版物
Communications Biology
Volume 5, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-08-30
DOI
10.1038/s42003-022-03845-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of permissive amber suppression sites for efficient non-canonical amino acid incorporation in mammalian cells
- (2021) Michael D Bartoschek et al. NUCLEIC ACIDS RESEARCH
- PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain
- (2021) Maorong Wen et al. Nature Communications
- Genetically incorporated crosslinkers reveal NleE attenuates host autophagy dependent on PSMD10
- (2021) Jingxiang Li et al. eLife
- Protein homodimer sequestration with small molecules: Focus on PD-L1
- (2020) Christian Bailly et al. BIOCHEMICAL PHARMACOLOGY
- Genetically encoded selective cross-linkers and emerging applications
- (2020) Haiyan Ren BIOCHEMICAL SOCIETY TRANSACTIONS
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1
- (2020) Dan Zhu et al. CELL DEATH AND DIFFERENTIATION
- Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
- (2019) Han Yao et al. Nature Biomedical Engineering
- Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
- (2019) Solène-Florence Kammerer-Jacquet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Structural basis for functional interactions in dimers of SLC26 transporters
- (2019) Yung-Ning Chang et al. Nature Communications
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- Dynamic tuneable G protein-coupled receptor monomer-dimer populations
- (2018) Patricia M. Dijkman et al. Nature Communications
- A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018)
- (2018) Shabnam Shaabani et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Proteomic identification of protein tyrosine phosphatase and substrate interactions in living mammalian cells by genetic encoding of irreversible enzyme inhibitors
- (2018) Hongting Tang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Palmitoylation stabilizes PD-L1 to promote breast tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- HIP1R targets PD-L1 to lysosomal degradation to alter T cell–mediated cytotoxicity
- (2018) Huanbin Wang et al. Nature Chemical Biology
- A quaternary tetramer assembly inhibits the deubiquitinating activity of USP25
- (2018) Bing Liu et al. Nature Communications
- Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
- (2017) Katarzyna Guzik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Expanding and reprogramming the genetic code
- (2017) Jason W. Chin NATURE
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spontaneous and specific chemical cross-linking in live cells to capture and identify protein interactions
- (2017) Bing Yang et al. Nature Communications
- A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover
- (2017) Egon Deyaert et al. Nature Communications
- PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
- (2017) Maria Gato-Cañas et al. Cell Reports
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
- (2016) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- EGFR oligomerization organizes kinase-active dimers into competent signalling platforms
- (2016) Sarah R. Needham et al. Nature Communications
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
- (2016) Chia-Wei Li et al. Nature Communications
- Mechanism of FGF receptor dimerization and activation
- (2016) Sarvenaz Sarabipour et al. Nature Communications
- Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)
- (2016) Krzysztof M. Zak et al. Oncotarget
- Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
- (2015) Naiyer A Rizvi et al. LANCET ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Grb2 monomer–dimer equilibrium determines normal versus oncogenic function
- (2015) Zamal Ahmed et al. Nature Communications
- STIM1 dimers undergo unimolecular coupling to activate Orai1 channels
- (2015) Yandong Zhou et al. Nature Communications
- Genetically Encoding an Electrophilic Amino Acid for Protein Stapling and Covalent Binding to Native Receptors
- (2014) Xiao-Hua Chen et al. ACS Chemical Biology
- Proximity-Enabled Protein Crosslinking through Genetically Encoding Haloalkane Unnatural Amino Acids
- (2014) Zheng Xiang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Major ligand-induced rearrangement of the heptahelical domain interface in a GPCR dimer
- (2014) Li Xue et al. Nature Chemical Biology
- Adding an unnatural covalent bond to proteins through proximity-enhanced bioreactivity
- (2013) Zheng Xiang et al. NATURE METHODS
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dimeric structure of PD-L1: functional units or evolutionary relics?
- (2010) Yong Chen et al. Protein & Cell
- Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
- (2009) M. Ahmadzadeh et al. BLOOD
- Efficient expression of tyrosine-sulfated proteins in E. coli using an expanded genetic code
- (2009) Chang C Liu et al. Nature Protocols
- The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
- (2008) D. Y.-w. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search